Stocks/APLD

APLD three-lens brief

Evidence-based stock research on APLD. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 08:00 ET
$17.25$25.78$50.73

Performance

1W
-0.5%
1M
-13.2%
3M
6M
YTD
1Y
3Y
5Y
APLD · Nightly brief
Concern

Price down 5.01% in the last session — a material single-day move. · 50-day MA below 200-day MA (death-cross regime); price below both.

  • Price down 5.01% in the last session — a material single-day move.
  • 50-day MA below 200-day MA (death-cross regime); price below both.
  • Currently unprofitable on a trailing basis — no P/E multiple available.
  • Analyst mean target $74.23 — 188% above current (11 analysts).
  • Negative free cash flow last quarterly (-$4.96B).

APLD closed at $25.78 (-5.01%) as of 2026-09-11. Market cap: $7.33B. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $74.23 — 188% above current (11 analysts).. Concerns: price down 5.01% in the last session — a material single-day move.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $258.75M, net income -$111.58M, free cash flow -$4.96B. Watching for: 2026-10-08 earnings release (27 days out).

Market ✓· Fundamentals ✓· 1 events
Informational only · Not investment advice
Three-lens method

Why three lenses on APLD, not one.

A single reasoning model has blind spots it doesn’t know about. We examine APLDacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/APLD"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath APLD brief"></iframe>